More...Snapshot
Alzheimer’s disease (AD), also referred to simply as Alzheimer’s, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer?s Disease Drug market will reach Volume Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes indu
Table of Content
1 Industry Overview
1.1 Alzheimer?s Disease Drug Industry
1.1.1 Overview
1.1.2 Development of Alzheimer?s Disease Drug
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Alzheimer?s Disease Drug Market by Type
3.1 Segment